🇳🇱 Netherlands Country × Condition
glioblastoma Clinical Trials in Netherlands
Active clinical trials for glioblastoma with research sites in Netherlands. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇳🇱 Netherlands
Active Trials in Netherlands (4)
NCT03861299
Recruiting
The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
Enrollment
246 pts
Country
🇳🇱 Netherlands
Jasper Gerritsen
View Trial → NCT06273176
Recruiting
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
Enrollment
225 pts
Country
🇳🇱 Netherlands
Erasmus Medical Center
View Trial → NCT06118723
Recruiting
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
Enrollment
784 pts
Country
🇳🇱 Netherlands
Jasper Gerritsen
View Trial → NCT06623565
Recruiting
Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques
Enrollment
30 pts
Country
🇳🇱 Netherlands
Amsterdam UMC, location VUmc
View Trial → Frequently Asked Questions
How many glioblastoma clinical trials are active in Netherlands?
There are currently 4 active clinical trials for glioblastoma with sites in Netherlands, of which 4 are actively recruiting patients.
How can I join a glioblastoma clinical trial in Netherlands?
To join a glioblastoma clinical trial in Netherlands, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Netherlands directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are glioblastoma trials in Netherlands?
Active glioblastoma trials in Netherlands span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology